tradingkey.logo
tradingkey.logo
Search

LeMaitre Vascular Inc

LMAT
Add to Watchlist
101.320USD
-0.870-0.85%
Close 07-31 16:00ETQuotes delayed by 15 min
2.32BMarket Cap
36.84P/E TTM

LeMaitre Vascular Inc

101.320
-0.870-0.85%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.85%

5 Days

+5.99%

1 Month

+2.61%

6 Months

+19.24%

Year to Date

+24.93%

1 Year

+25.02%

Key Figures
101.340Open
102.100High
234.19KVolume
36.84P/E TTM
30.47P/E Dynamic
0.850Dividend TTM
1.02%Turnover Ratio
102.190Prev. Close
99.310Low
18.39MTurnover
52.57P/E Static
5.69P/B
0.84%Div Yield TTM
10.53%ROA
118.01052wk High
0.88Volume Ratio
44.04MNet Profit
22.85MShares
2.7501EPS TTM
0.55Beta
16.55%ROE
79.00552wk Low
2.73%Amplitude
72.72%Gross Margin
2.32BMarket Cap
-0.81Reward/Risk
1.83%Risk Rate

Key Insights

LeMaitre Vascular Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 17 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 118.75.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

LeMaitre Vascular Inc's Score

Industry at a Glance

Industry Ranking
17 / 199
Overall Ranking
64 / 4281
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

LeMaitre Vascular Inc Highlights

StrengthsRisks
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 29.00% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 249.60M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.
Undervalued
The company’s latest PE is 36.84, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 23.53M shares, increasing 3.50% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 10.24K shares of this stock.

Analyst Rating

Based on 9 analysts
Buy
Current Rating
118.750
Target Price
+14.66%
Upside Space

LeMaitre Vascular Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 9 analysts
Buy
Current Rating
118.750
Target Price
+17.20%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

88
Total
4
Median
7
Average
Company name
Ratings
Analysts
LeMaitre Vascular Inc
LMAT
9
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18

Indicators

Indicators
Sell(2)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.163
Buy
RSI(14)
53.368
Neutral
STOCH(KDJ)(9,3,3)
66.809
Neutral
ATR(14)
3.788
Low Volatility
CCI(14)
21.075
Neutral
Williams %R
37.279
Buy
TRIX(12,20)
0.143
Sell
StochRSI(14)
39.392
Sell
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
101.662
Sell
MA10
100.250
Buy
MA20
101.074
Buy
MA50
97.246
Buy
MA100
103.230
Sell
MA200
95.605
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

LeMaitre Vascular Inc Info

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
Ticker SymbolLMAT
CompanyLeMaitre Vascular Inc
CEOLemaitre (George W)
Websitehttps://www.lemaitre.com/

Shareholders

Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.65%
Conestoga Capital Advisors, LLC
6.46%
LeMaitre (George W)
6.30%
First Trust Advisors L.P.
4.11%
Vanguard Capital Management, LLC
3.99%
Other
66.48%

FAQs

What is the current price of LeMaitre Vascular Inc (LMAT)?

The current price of LeMaitre Vascular Inc (LMAT) is 101.32.

What is the symbol of LeMaitre Vascular Inc?

The ticker symbol of LeMaitre Vascular Inc is LMAT.

What is the 52-week high of LeMaitre Vascular Inc?

The 52-week high of LeMaitre Vascular Inc is 118.01.

What is the 52-week low of LeMaitre Vascular Inc?

The 52-week low of LeMaitre Vascular Inc is 79.00.

What is the market capitalization of LeMaitre Vascular Inc?

The market capitalization of LeMaitre Vascular Inc is 2.31B.

Is LeMaitre Vascular Inc (LMAT) currently rated as Buy, Hold, or Sell?

According to analysts, LeMaitre Vascular Inc (LMAT) has an overall rating of Buy, with a price target of 118.75.

What is the Earnings Per Share (EPS TTM) of LeMaitre Vascular Inc (LMAT)?

The Earnings Per Share (EPS TTM) of LeMaitre Vascular Inc (LMAT) is 2.55.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.